Unravelling benzazepines and aminopyrimidine as multi-target therapeutic repurposing drugs for EGFR V774M mutation in neuroglioma patients.

Jitender SinghKrishan L KhandujaPramod K Avti

Published in: BioImpacts : BI (2023)

Therefore, compounds (ZINC000012503187 and ZINC000068153186) can effectively target both the unaltered/altered EGFRs as multi-target therapeutic repurposing drugs towards neuroglioma.

Keyphrases

small cell lung cancer
ejection fraction
newly diagnosed
prognostic factors
epidermal growth factor receptor
tyrosine kinase
oxide nanoparticles
drug induced